General MedicationsORALStandard
WARFARIN SODIUM
WARFARIN SODIUM
Standard Dose
1MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview WARFARIN SODIUM is listed in Drugs@FDA under application 202202 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient WARFARIN SODIUM Form and strength TABLET;ORAL - 1MG Sponsor AMNEAL PHARMS Submission history Latest submission status date: 2022-08-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview WARFARIN SODIUM is listed in Drugs@FDA under application 202202 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient WARFARIN SODIUM Form and strength TABLET;ORAL - 1MG Sponsor AMNEAL PHARMS Submission history Latest submission status date: 2022-08-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.